Blog

I have a confession to make. During the early years that the Pearson research team and I were developing the D-KEFS™ Advanced (all-digital tests of executive functions), I was reluctant to use digital assessments in my private practice. I felt a bit hypocritical; here we were striving to create state-of-the-art digital tests of executive functions, yet in my own practice, I was clinging to tried-and-true print versions of tests, even for questionnaires like the MMPI-3^®.

When Dr. Miia Kivipelto launched the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, better known as the FINGER trial, in 2009, the field of dementia prevention was much different.

“At that time, [the focus was only on] high age and genetic factors,” Kivipelto said. “Now we know that 45% of these risk factors are there throughout the whole life course and that’s why we say that it’s never too early to … prevent dementia.”

Kivipelto, a Finnish neuroscientist and professor who specializes in dementia and Alzheimer’s disease, joined John Harrison, Ph.D., CPsychol, CSci, AFBPsS, an associate professor at Alzheimercentrum, AUmc, Amsterdam, for the Pearson-sponsored podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” to share insights into her research.

What decades of research reveal about brain health, early detection, and the future of dementia care

I’m excited to announce the launch of the D-KEFS™ Advanced. The original D-KEFS™, published in 2001, arrived on the eve of the mobile digital revolution. By 2009, as we began planning its revision, we explored how best to harness this rapidly evolving technology. Our solution was to “go all in” by developing exclusively digital tests of executive functions, freeing ourselves from the constraints of producing equivalent paper-and-pencil versions.

What if one of the most overlooked proteins in the brain turned out to hold the key to understanding—and eventually treating — Alzheimer’s disease?

That question was at the center of a recent Pearson-sponsored podcast series, The Progress Profile: Alzheimer’s Research in Focus. Leading Alzheimer’s researcher Dr. Philip Scheltens joined moderator moderator, John Harrison, Ph.D., CPsychol, CSci, AFBPsS, an associate professor at Alzheimercentrum, AUmc, Amsterdam, to explore how tau has moved from a supporting role in the “amyloid hypothesis” to a central player in diagnosis, imaging, treatment, and precision medicine.

How CAT-MH^® helped one practice save lives

In the world of behavioral health, every moment counts. When someone reaches out for help, there's often a narrow window of opportunity—one that can close quickly if the right support isn't available immediately. For Bernie Dyme, a licensed clinical social worker with over four decades of experience, finding ways to maximize that critical window became essential as his practice grew.